Modeling statin-induced myopathy with hiPSC-derived myocytes reveals that impaired proteostasis underlies the myotoxicity and is targetable for the prevention
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00714.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Xiaolin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Food Biochemistry, Department of Applied Biological Chemistry, Graduate School of Life and Agricultural Sciences, The University of Tok…. Hauptthemen laut MEDLINE: Hydroxymethylglutaryl-CoA Reductase Inhibitors, Induced Pluripotent Stem Cells, Proteostasis, Muscular Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development (AMED), MEXT | Japan Society for the Promotion of Science (JSPS), Japan Society of Nutrition and Food Science (JSNFS).
Abstract (Originalsprache)
This work established a human induced pluripotent stem (iPS) cell-based model for statin-induced myopathy (SIM) and demonstrated that blocking the mevalonate pathway disrupts the balance between protein synthesis and degradation, leading to myopathy. Furthermore, the present study showed that pharmacological inhibition of the transcription factor FOXO1 prevents SIM in human iPS cell-derived myocytes, suggesting that FOXO1 is a key mediator of SIM and a potential target for its prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Food Biochemistry, Department of Applied Biological Chemistry, Graduate School of Life and Agricultural Sciences, The University of Tokyo, Tokyo, Japan.
- Nutri-Life Science Laboratory, Department of Applied Biological Chemistry, Graduate School of Life and Agricultural Sciences, The University of Tokyo, Tokyo, Japan.
- Laboratory of Genome and Biosignals, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
- Center for iPS Cell Research and Application, Kyoto University, Kyoto, Japan.
ORCID-Profile: Hidetoshi Sakurai, Yu Takahashi, Ryuichiro Sato, Yoshio Yamauchi
Förderung
- Japan Agency for Medical Research and Development (AMED)
- MEXT | Japan Society for the Promotion of Science (JSPS)
- Japan Society of Nutrition and Food Science (JSNFS)
- Tojuro Iijima Foundation for Food Science and Technology
Zitieren
APA
Zhao, X., Ni, L., Kubo, M., Matsuto, M., Sakurai, H., Shimizu, M., Takahashi, Y., Sato, R., & Yamauchi, Y. (2025). Modeling statin-induced myopathy with hiPSC-derived myocytes reveals that impaired proteostasis underlies the myotoxicity and is targetable for the prevention. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00714.2024
Vancouver
Zhao X, Ni L, Kubo M, Matsuto M, Sakurai H, Shimizu M, et al. Modeling statin-induced myopathy with hiPSC-derived myocytes reveals that impaired proteostasis underlies the myotoxicity and is targetable for the prevention. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00714.2024
BibTeX
@article{Zhao2025,
author = {Zhao, Xiaolin and Ni, Liyang and Kubo, Miharu and Matsuto, Mariko and Sakurai, Hidetoshi and Shimizu, Makoto and Takahashi, Yu and Sato, Ryuichiro and Yamauchi, Yoshio},
title = {Modeling statin-induced myopathy with hiPSC-derived myocytes reveals that impaired proteostasis underlies the myotoxicity and is targetable for the prevention},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00714.2024}
}
EUVIMED